China Universal Asset Management Company’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Sell
13,901
-324
-2% -$4.34K 0.01% 366
2026
Q1
$212K Buy
14,225
+1,207
+9% +$26.9K 0.02% 347
2025
Q4
$325K Buy
13,018
+987
+8% +$17.6K 0.03% 294
2025
Q3
$118K Sell
12,031
-1,711
-12% -$10.3K 0.01% 373
2025
Q2
$58.5K Sell
13,742
-1,150
-8% -$5.13K 0.01% 409
2025
Q1
$56K Buy
14,892
+2,743
+23% +$13.8K 0.01% 413
2024
Q4
$70.8K Buy
12,149
+1,135
+10% +$11.3K 0.01% 424
2024
Q3
$132K Buy
11,014
+4,442
+68% +$56.8K 0.01% 333
2024
Q2
$71.1K Sell
6,572
-3,990
-38% -$43.3K 0.01% 327
2024
Q1
$120K Buy
10,562
+4,221
+67% +$54.5K 0.02% 353
2023
Q4
$89K Buy
+6,341
New +$85.2K 0.02% 298
2022
Q4
– Sell
-378
Closed -$1K – 437
2022
Q3
$1K Buy
+378
New +$1.6K ﹤0.01% 404

Other funds holding OLMA

China Universal Asset Management Company's OLMA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Olema Pharmaceuticals (OLMA) stake by 2.3% in Q2 2026, selling an estimated $4.34K and leaving 13,901 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #366.

China Universal Asset Management Company first reported a position in OLMA in Q3 2022 and has held it in 12 quarters since. The position peaked at $325K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • China Universal Asset Management Company held 13,901 shares of Olema Pharmaceuticals worth $174K as of Q2 2026.
  • China Universal Asset Management Company sold 324 Olema Pharmaceuticals shares in Q2 2026, an estimated $4.34K.
  • Olema Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #366 holding.
  • China Universal Asset Management Company first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • China Universal Asset Management Company's Olema Pharmaceuticals position peaked at $325K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.